Dogwood Therapeutics Reports Positive Results from IMC-2 Study on Long-COVID Related Fatigue and Sleep Disturbance
IMC-2 treatment shows significant reductions in Long-COVID fatigue and sleep issues compared to placebo, informing future Phase 2 study design.Quiver AI SummaryDogwood Therapeutics, Inc. announced promising...